All articles by
AbbVie Completes Acquisition of ImmunoGen
ImmunoGen’s pipeline complements AbbVie’s existing oncology pipeline with potential to be transformative across multiple solid tumors and hematologic malignancies
J&J’s nipocalimab secures FDA breakthrough status to treat HDFN
The breakthrough therapy designation was based on results from the proof-of-concept Phase 2 open-label UNITY clinical trial in which 54% of pregnant subjects who received nipocalimab achieved a live birth
Hemab says HMB-001 was well tolerated in Phase 1 Glanzmann Thrombasthenia trial
HMB-001 is designed to bind and stabilise endogenous Factor VIIa using one antibody arm, while the second arm targets TLT-1 on activated platelets
Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
DISC-3405 is an investigational, anti-TMPRSS6 monoclonal antibody designed to increase hepcidin production and suppress serum iron
Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions
New partnership model leverages Aptar Digital Health’s capabilities to support the development and operation of new and existing digital health solutions globally
Jazz Pharmaceuticals to buy Redx’s KRAS inhibitor programme
Under the terms of the deal, Jazz will secure all rights, patents, title, and interest in exchange for an upfront payment of $10m along with $870m in research, regulatory, and commercial milestones
Telix to buy QSAM Biosciences and its bone cancer targeting platform
QSAM is focused on the development of therapeutic radiopharmaceuticals for primary and metastatic bone cancer and its initial technology, 153Sm-DOTMP, is a clinical-stage bone-targeting radiopharmaceutical originally developed by IsoTherapeutics Group and now owned by IGL Pharma
US FDA grants priority review to GSK’s Arexvy for RSV protection in adults aged 50-59 years
The vaccine’s application is based on the positive findings from a Phase 3 immunogenicity trial that showed an immune response and acceptable tolerability profile in individuals aged 50-59 at increased risk
Stemson Therapeutics Announces Technological Breakthrough in New Hair Growth
Demonstrates new engineered functional hair follicles in humanized mice
Ambience Healthcare Raises $70m to Scale the Most Comprehensive AI Operating System for Healthcare Organizations
The Ambience AI operating system consists of a holistic suite of applications, designed to alleviate clinician burnout, improve overall system efficiency, and enable high-quality care